T-Cell-Rich B-Cell Lymphoma

Publisher： Karger

E-ISSN： 1423-0232|61|4|257-264

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.4, 2001-11, pp. : 257-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Derangement of the T‐cell repertoire in patients with B‐cell non‐Hodgkin's lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 298-309

John Wiley & Sons Inc

Access to resources Recommend Favorite

γδ T‐cell‐rich benign cutaneous disorders: good or bad?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. : 315-316

John Wiley & Sons Inc

Access to resources Recommend Favorite

Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 415-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 156-161

Karger

Access to resources Recommend Favorite